Skip to main content
Top
Published in: Breast Cancer Research 2/2006

Open Access 01-04-2006 | Research article

Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity

Authors: Debra Hawes, Susan Downey, Celeste Leigh Pearce, Sue Bartow, Peggy Wan, Malcolm C Pike, Anna H Wu

Published in: Breast Cancer Research | Issue 2/2006

Login to get access

Abstract

Introduction

Increased mammographic density is a strong risk factor for breast cancer. The reasons for this are not clear; two obvious possibilities are increased epithelial cell proliferation in mammographically dense areas and increased breast epithelium in women with mammographically dense breasts. We addressed this question by studying the number of epithelial cells in terminal duct lobular units (TDLUs) and in ducts, and their proliferation rates, as they related to local breast densities defined histologically within individual women.

Method

We studied deep breast tissue away from subcutaneous fat obtained from 12 healthy women undergoing reduction mammoplasty. A slide from each specimen was stained with the cell-proliferation marker MIB1. Each slide was divided into (sets of) areas of low, medium and high density of connective tissue (CT; highly correlated with mammographic densities). Within each of the areas, the numbers of epithelial cells in TDLUs and ducts, and the numbers MIB1 positive, were counted.

Results

The relative concentration (RC) of epithelial cells in high compared with low CT density areas was 12.3 (95% confidence interval (CI) 10.9 to 13.8) in TDLUs and 34.1 (95% CI 26.9 to 43.2) in ducts. There was a much smaller difference between medium and low CT density areas: RC = 1.4 (95% CI 1.2 to 1.6) in TDLUs and 1.9 (95% CI 1.5 to 2.3) in ducts. The relative mitotic rate (RMR; MIB1 positive) of epithelial cells in high compared with low CT density areas was 0.59 (95% CI 0.53 to 0.66) in TDLUs and 0.65 (95% CI 0.53 to 0.79) in ducts; the figures for the comparison of medium with low CT density areas were 0.58 (95% CI 0.48 to 0.70) in TDLUs and 0.66 (95% CI 0.44 to 0.97) in ducts.

Conclusion

Breast epithelial cells are overwhelmingly concentrated in high CT density areas. Their proliferation rate in areas of high and medium CT density is lower than that in low CT density areas. The increased breast cancer risk associated with increased mammographic densities may simply be a reflection of increased epithelial cell numbers. Why epithelium is concentrated in high CT density areas remains to be explained.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.PubMed Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987, 9: 146-174.PubMed
2.
go back to reference Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.PubMed
3.
go back to reference Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH: Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res. 2005, 7: R605-R608. 10.1186/bcr1260.CrossRefPubMedPubMedCentral Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH: Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res. 2005, 7: R605-R608. 10.1186/bcr1260.CrossRefPubMedPubMedCentral
4.
go back to reference Perkins CI, Hotes J, Kohler BA, Howe HL: Association between breast cancer laterality and tumor location, United States, 1994-1998. Cancer Causes Control. 2004, 15: 637-645. 10.1023/B:CACO.0000036171.44162.5f.CrossRefPubMed Perkins CI, Hotes J, Kohler BA, Howe HL: Association between breast cancer laterality and tumor location, United States, 1994-1998. Cancer Causes Control. 2004, 15: 637-645. 10.1023/B:CACO.0000036171.44162.5f.CrossRefPubMed
5.
go back to reference Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003, 5: R129-R135. 10.1186/bcr622.CrossRefPubMedPubMedCentral Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003, 5: R129-R135. 10.1186/bcr622.CrossRefPubMedPubMedCentral
6.
go back to reference Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao M-S, Khokha L, Martin L, Boyd N: The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 343-349. 10.1158/1055-9965.EPI-04-0490.CrossRefPubMed Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao M-S, Khokha L, Martin L, Boyd N: The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005, 14: 343-349. 10.1158/1055-9965.EPI-04-0490.CrossRefPubMed
7.
go back to reference Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR: The prevalence of benign, atypical and malignant breast lesions in populations at different risk for breast cancer. Cancer. 1987, 60: 2751-2760.CrossRefPubMed Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR: The prevalence of benign, atypical and malignant breast lesions in populations at different risk for breast cancer. Cancer. 1987, 60: 2751-2760.CrossRefPubMed
8.
go back to reference Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC: Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat. 1996, 37: 229-236. 10.1007/BF01806504.CrossRefPubMed Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC: Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage. Breast Cancer Res Treat. 1996, 37: 229-236. 10.1007/BF01806504.CrossRefPubMed
9.
go back to reference Shi S-R, Cote R, Chaiwun B, Young LL, Shi Y, Hawes D, Chen T, Taylor CR: Standardization of immunochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem. 1998, 6: 89-96. 10.1097/00022744-199806000-00006.CrossRef Shi S-R, Cote R, Chaiwun B, Young LL, Shi Y, Hawes D, Chen T, Taylor CR: Standardization of immunochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections. Appl Immunohistochem. 1998, 6: 89-96. 10.1097/00022744-199806000-00006.CrossRef
10.
go back to reference Bartow SA, Mettler FA, Black WC, Moskowitz M: Correlations between radiographic patterns and morphology of the female breast. Prog Surg Path. 1982, 4: 263-275. Bartow SA, Mettler FA, Black WC, Moskowitz M: Correlations between radiographic patterns and morphology of the female breast. Prog Surg Path. 1982, 4: 263-275.
11.
go back to reference Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999, 84: 4017-4024. 10.1210/jc.84.11.4017.PubMed Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999, 84: 4017-4024. 10.1210/jc.84.11.4017.PubMed
Metadata
Title
Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity
Authors
Debra Hawes
Susan Downey
Celeste Leigh Pearce
Sue Bartow
Peggy Wan
Malcolm C Pike
Anna H Wu
Publication date
01-04-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1408

Other articles of this Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine